In this issue...
Drug safety advice
- Varenicline: adverse psychiatric reactions, including depression
- Tigecycline: new formulation affects compatibility
Yellow Card scheme update
- Reporting by community pharmacists is encouraged for OTCs
Hot topic
- Ezetimibe and possible increased risk of cancer: results of SEAS study
Stop Press
- Rimonabant: European suspension of marketing authorisation
- Inhaled anticholinergics: recent published data for risk of death or stroke
- Paracetamol use in infancy: no strong evidence for asthma link
Other information from the MHRA
- Patient Information Leaflet of the month: Telfast
- ‘My medicine’: new section on MHRA website
- Device bulletin: use of in vitro diagnostic devices with other medical equipment
- Herbal medicines: packaging shows MHRA approval
Drug Safety Update: Volume 2, Issue 4, November 2008 
